GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Timber Pharmaceuticals Inc (FRA:BPC) » Definitions » Payments to Suppliers for Goods and Services

Timber Pharmaceuticals (FRA:BPC) Payments to Suppliers for Goods and Services


View and export this data going back to 2020. Start your Free Trial

What is Timber Pharmaceuticals Payments to Suppliers for Goods and Services?

Payments to Suppliers for Goods and Services only applicable to companies reporting Cash Flow from Operations in direct method.


Timber Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Timber Pharmaceuticals Inc (FRA:BPC) » Definitions » Payments to Suppliers for Goods and Services
Traded in Other Exchanges
N/A
Address
3 Mountain View Road, Suite 100, Warren, NJ, USA, 07059
Timber Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its investigational therapies have mechanisms of action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing, and control) and safety profiles. The company is focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), X-linked recessive CI (XLRI) and autosomal recessive CI (ARCI), and other sclerotic skin diseases. The company's late-stage program is TMB-001., and TMB-003 is the earliest-stage program.